Webinar
With more than half of the world staying at home and the economic impact of COVID-19 growing, examining the role of media both during and after the pandemic is more important than ever.
How can the news media ensure factual, verifiable information is delivered to the public? What proactive actions should the media—and the social media platforms through which many access the news—take to curb the rise of "fake news" and disinformation? And what is the responsibility of consumers of media?

Image

Laura Deal Lacey
Executive Vice President, Milken Institute International
Laura Deal Lacey is the executive vice president, MI International at the Milken Institute. She is also the chairman of the board of FWD Insurance (Singapore), serves as the independent director on the SGX-listed Pacific Century Regional Development (PCRD), and is a member of the Singapore Management University's The Sim Kee Boon Institute for Financial Economics Advisory Board.
Image

Curtis S. Chin
Chair, Senior Fellows; Senior Advisor, Global Markets, Milken Institute
Curtis S. Chin is Chair, Asia Fellows; Senior Advisor, Global Markets at the Milken Institute. He is a former U.S. ambassador to the Asian Development Bank (ADB), an advisory board member of the Asian American Federation, and a media presence and voice on where East meets West—from business, trade & culture to issues facing the Asian American community.
Related Content
-
Implementing a Dynamic Venture Philanthropy Practice
How can nonprofit organizations develop and implement a venture philanthropy investment strategy? As part of The Research Acceleration and Innovation Network (TRAIN) webinar series, FasterCures collaborated with MI Philanthropy to take a...View Webinar -
Building More Diverse and Inclusive Patient Organizations and Communities
How are patient organizations taking on the challenge of diversity, equity, and inclusion within biomedical research to create better health outcomes for all patient populations, especially those historically excluded from research and...View Webinar -
Advances in Science: A Decade of Progress in Alzheimer’s Disease Research
Rajiv Ahuja, associate director at the Milken Institute, focusing on the future of aging, moderates this Advances in Science webinar with featured guest Richard J. Hodes, M.D., Director of the National Institute on Aging (NIA) at the...View Webinar -
Venture Philanthropy in Action: A Case Study of EB Research Partnership and ProQR
How are nonprofit organizations leveraging venture philanthropy to accelerate the development of treatments and cures? As part of The Research Acceleration and Innovation Network (TRAIN) webinar series, FasterCures takes a deeper dive into...View Webinar -
California: The Post-COVID Future of Work
The COVID-19 pandemic has accelerated job displacement and unemployment trends—in California and across the country—precipitated by advancements in technology and automation. Although these disruptive forces impacting the workforce are not...View Webinar -
Implementing a Dynamic Venture Philanthropy Practice
How can nonprofit organizations develop and implement a venture philanthropy investment strategy? As part of The Research Acceleration and Innovation Network (TRAIN) webinar series, FasterCures collaborated with MI Philanthropy to take a...View Webinar -
California’s Green and Blue Jobs
Despite significant advances in renewable energy, biotech, and life sciences jobs, the journey from generating breakthrough discoveries to creating accessible jobs across green and blue industries remains difficult to quantify. Industries...View Webinar -
The Great Reshuffling and Beyond
One thing has been made abundantly clear during the COVID-19 pandemic. Californians are quitting their jobs at unprecedented rates. The recent job reports only continue to solidify this notion. Whether searching for better pay, more...View Webinar -
Experts Discuss Long-Term Data Collection for Cell and Gene Therapies
In a webinar on September 23, 2020, FasterCures brought together Peter Marks, director of the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research, Gwen Nichols, chief medical officer of the Leukemia &...View Webinar